- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02708121
Increasing Uptake of Behavioral Weight Loss Programs Among Primary Care Patients
June 21, 2019 updated by: University of Florida
This pilot trial will test feasibility and acceptability of a primary care-based intervention that aims to increase the portion of patients who enter evidence-based behavioral weight loss treatment.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This trial is a pilot, pragmatic cluster randomized trial conducted in primary care clinics to determine intervention acceptability and the feasibility of proposed study protocol.
Study Type
Interventional
Enrollment (Actual)
66
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
North Carolina
-
Durham, North Carolina, United States, 27710
- Duke University Medical Center
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 75 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Primary care provider Inclusion criteria:
- Employed by Duke PCRC clinic as primary care provider at least ½ FTE.
- Has a primary adult panel
- Has worked at Duke PCRC clinic for at least one year
Patient inclusion criteria
- BMI ≥ 30 kg/m2 as measured at any clinic in previous 12 months.
- English speaking
- Self-report BMI ≥ 29 kg/m2 (to allow for under-reporting)
- Regular email usage, defined as accessing email 3 or more times per week (on home or work computer or cell phone)
- Age 18-75
- Clinical appointment (well visit or chronic care visit) with enrolled Duke provider in 2-6 weeks of record review.
- At least one prior appointment with the provider they are scheduled to see at target clinical appt.
- Has a valid email address in electronic health records.
Patient exclusion criteria:
- In weight loss treatment program in past year
- Unable to read content on websites without any assistance
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention arm
Participant receives intervention to motivate weight loss treatment initiation and access to weight loss treatment.
|
Participants complete web-based assessment and receive tailored feedback to motivate weight loss treatment initiation and informed that they have access to weight loss treatment.
Other Names:
|
|
Active Comparator: Comparator Arm
Participant receives access to weight loss treatment alone.
|
Participants informed that they have access to weight loss treatment.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants Attending 6 Month Follow-up Appointment
Time Frame: 6 months
|
Count of enrolled participants who attend 6 month follow-up appointment
|
6 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Intervention Acceptability (Acceptability Outcome)
Time Frame: 1 month
|
Ratings on series of items developed by study team to assess patient perception of acceptability of the intervention.
Items were created by study team.
Possible range of 1 (strongly disagree) to 5 (strongly agree).
Higher score reflects greater acceptability except for item 11.
|
1 month
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of Participants Who Initiated Treatment Based on Program-provided Data and Self-report
Time Frame: 6 months
|
Number of participants who initiate evidence-based weight loss treatment.
Initiation is defined as completing at least one session (either group in-person session, one-on-one)
|
6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Megan A McVay, PhD, Duke University
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
March 3, 2017
Primary Completion (Actual)
February 23, 2018
Study Completion (Actual)
February 23, 2018
Study Registration Dates
First Submitted
March 10, 2016
First Submitted That Met QC Criteria
March 10, 2016
First Posted (Estimate)
March 15, 2016
Study Record Updates
Last Update Posted (Actual)
June 25, 2019
Last Update Submitted That Met QC Criteria
June 21, 2019
Last Verified
June 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRB201701301-N
- 1K23HL127334 (U.S. NIH Grant/Contract)
- Pro00079803 (Other Identifier: Duke Unversity)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | Obesity and Obesity-related Medical ConditionsUnited States
-
Central Hospital, Nancy, FranceNot yet recruiting
-
Helsinki University Central HospitalKarolinska Institutet; Folkhälsan Researech CenterEnrolling by invitation
-
Istanbul Medipol University HospitalMedipol UniversityCompletedObesity, Morbid | Obesity, Adolescent | Obesity, Abdominal | Weight, Body | Obesity, VisceralTurkey
-
Washington University School of MedicinePatient-Centered Outcomes Research Institute; Pennington Biomedical Research... and other collaboratorsCompletedOvernutrition | Nutrition Disorders | Overweight | Body Weight | Pediatric Obesity | Body Weight Changes | Childhood Obesity | Weight Gain | Adolescent Obesity | Obesity, Childhood | Overweight and Obesity | Overweight or Obesity | Overweight AdolescentsUnited States
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
The Hospital for Sick ChildrenCompleted
-
Ihuoma EneliCompletedObesity, ChildhoodUnited States
-
Dr. Christopher McGowanRecruitingObesity Prevention | Obesity Recidivism | Obesity and Overweight | GLP-1 | Obesity and Obesity-related Medical Conditions | Ablation TechniquesUnited States
-
Azienda Ospedaliero-Universitaria Consorziale Policlinico...Institute of Biomembranes, Bioenergetics and Molecular Biotechnologies; Istituti... and other collaboratorsCompletedMorbid Obesity | Metabolically Healthy ObesityItaly
Clinical Trials on Motivational Intervention
-
San Diego State UniversityCompletedDrug AbuseUnited States
-
Jordi Gol i Gurina FoundationUniversity Rovira i VirgiliUnknown
-
Louis BhererCompleted
-
Fundacio d'Investigacio en Atencio Primaria Jordi...Instituto de Salud Carlos IIIUnknown
-
University of Wisconsin, MadisonNational Institute on Aging (NIA)Completed
-
Centers for Disease Control and PreventionWithdrawnAccidents, Traffic
-
Rhode Island HospitalNational Institute on Drug Abuse (NIDA)CompletedHepatitis C | HIV | Drug UseUnited States
-
VA Connecticut Healthcare SystemUnknown
-
Oregon Health and Science UniversityCompletedMotivation | Ultraviolet RaysUnited States
-
Stony Brook UniversityRecruiting